Introduction and Demographics

Key Insights

49% of respondents' organizations are working on the development of diagnostics, vaccination or treatment of COVID-19 in some way.
65% think that the COVID-19 vaccine response will have a long term impact on accelerated regulatory approval.
87% of respondents' supply chains are still being impacted by the pandemic.
48% currently have reduced pipelines due to the pandemic.
59% are working at home full time, compared to 68% in 2020

COVID-19 One Year On Report: Impacts on the Global Life Sciences Industry 2021

In April 2020, with the true extent of COVID-19 impacts only just fully emerging and lockdowns just being put in place in many parts of the world, Informa Connect Life Sciences asked the global life sciences community about the impacts the pandemic was having on the industry and their response to it. We got a huge response with over 600 industry professionals completing the survey, which provided the data for a fascinating report.

A year on, we wanted to see how the picture has changed, so conducted a follow up study of life sciences professionals from the pharma, biotech, medical device and regulatory industries around the world. The survey was completed 379 times and the data - presented in this report - reveals insights into how the global life sciences community has responded to the crisis, the impacts it has had on the different industries, and how the future looks.

Use the Contents menu in the top left to jump to any section or download this report as a PDF.

Demographics